Trial Profile
MULTICENTER, RANDOMIZED, DOUBLE-BLIND COMPARATIVE STUDY WITH THE REFERENCE PRODUCTS, FOR ASSESSMENT OF THERAPEUTIC SUPERIORITY OF THE COMBINATION CLINDAMYCIN-TRETINOIN/VERISFIELD, GEL, (1.0+0.025)%, (VERSUS THE MONOTHERAPY WITH CLINDAMYCIN OR TRETINOIN) FOR THE TOPICAL TREATMENT OF ACNE.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Feb 2013
Price :
$35
*
At a glance
- Drugs Clindamycin/tretinoin (Primary) ; Clindamycin; Tretinoin
- Indications Acne vulgaris
- Focus Therapeutic Use
- 22 Feb 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database.
- 22 Jun 2011 New trial record